Cargando…

Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic

BACKGROUND: Understanding immunity, incidence and risk factors of the 2009 influenza A(H1N1) pandemic (2009 H1N1) through a national seroprevalence study is necessary for informing public health interventions and disease modelling. METHODS AND FINDINGS: We collected 1687 serum samples and individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandaranayake, Don, Huang, Q. Sue, Bissielo, Ange, Wood, Tim, Mackereth, Graham, Baker, Michael G., Beasley, Richard, Reid, Stewart, Roberts, Sally, Hope, Virginia
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954793/
https://www.ncbi.nlm.nih.gov/pubmed/20976224
http://dx.doi.org/10.1371/journal.pone.0013211
_version_ 1782187953067393024
author Bandaranayake, Don
Huang, Q. Sue
Bissielo, Ange
Wood, Tim
Mackereth, Graham
Baker, Michael G.
Beasley, Richard
Reid, Stewart
Roberts, Sally
Hope, Virginia
author_facet Bandaranayake, Don
Huang, Q. Sue
Bissielo, Ange
Wood, Tim
Mackereth, Graham
Baker, Michael G.
Beasley, Richard
Reid, Stewart
Roberts, Sally
Hope, Virginia
author_sort Bandaranayake, Don
collection PubMed
description BACKGROUND: Understanding immunity, incidence and risk factors of the 2009 influenza A(H1N1) pandemic (2009 H1N1) through a national seroprevalence study is necessary for informing public health interventions and disease modelling. METHODS AND FINDINGS: We collected 1687 serum samples and individual risk factor data between November-2009 to March-2010, three months after the end of the 2009 H1N1 wave in New Zealand. Participants were randomly sampled from selected general practices countrywide and hospitals in the Auckland region. Baseline immunity was measured from 521 sera collected during 2004 to April-2009. Haemagglutination inhibition (HI) antibody titres of ≥1∶40 against 2009 H1N1 were considered seroprotective as well as seropositive. The overall community seroprevalence was 26.7% (CI:22.6–29.4). The seroprevalence varied across age and ethnicity. Children aged 5–19 years had the highest seroprevalence (46.7%;CI:38.3–55.0), a significant increase from the baseline (14%;CI:7.2–20.8). Older adults aged ≥60 had no significant difference in seroprevalence between the serosurvey (24.8%;CI:18.7–30.9) and baseline (22.6%;CI:15.3–30.0). Pacific peoples had the highest seroprevalence (49.5%;CI:35.1–64.0). There was no significant difference in seroprevalence between both primary (29.6%;CI:22.6–36.5) and secondary healthcare workers (25.3%;CI:20.8–29.8) and community participants. No significant regional variation was observed. Multivariate analysis indicated age as the most important risk factor followed by ethnicity. Previous seasonal influenza vaccination was associated with higher HI titres. Approximately 45.2% of seropositive individuals reported no symptoms. CONCLUSIONS: Based on age and ethnicity standardisation to the New Zealand Population, about 29.5% of New Zealanders had antibody titers at a level consistent with immunity to 2009 H1N1. Around 18.3% of New Zealanders were infected with the virus during the first wave including about one child in every three. Older people were protected due to pre-existing immunity. Age was the most important factor associated with infection followed by ethnicity. Healthcare workers did not appear to have an increased risk of infection compared with the general population.
format Text
id pubmed-2954793
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29547932010-10-25 Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic Bandaranayake, Don Huang, Q. Sue Bissielo, Ange Wood, Tim Mackereth, Graham Baker, Michael G. Beasley, Richard Reid, Stewart Roberts, Sally Hope, Virginia PLoS One Research Article BACKGROUND: Understanding immunity, incidence and risk factors of the 2009 influenza A(H1N1) pandemic (2009 H1N1) through a national seroprevalence study is necessary for informing public health interventions and disease modelling. METHODS AND FINDINGS: We collected 1687 serum samples and individual risk factor data between November-2009 to March-2010, three months after the end of the 2009 H1N1 wave in New Zealand. Participants were randomly sampled from selected general practices countrywide and hospitals in the Auckland region. Baseline immunity was measured from 521 sera collected during 2004 to April-2009. Haemagglutination inhibition (HI) antibody titres of ≥1∶40 against 2009 H1N1 were considered seroprotective as well as seropositive. The overall community seroprevalence was 26.7% (CI:22.6–29.4). The seroprevalence varied across age and ethnicity. Children aged 5–19 years had the highest seroprevalence (46.7%;CI:38.3–55.0), a significant increase from the baseline (14%;CI:7.2–20.8). Older adults aged ≥60 had no significant difference in seroprevalence between the serosurvey (24.8%;CI:18.7–30.9) and baseline (22.6%;CI:15.3–30.0). Pacific peoples had the highest seroprevalence (49.5%;CI:35.1–64.0). There was no significant difference in seroprevalence between both primary (29.6%;CI:22.6–36.5) and secondary healthcare workers (25.3%;CI:20.8–29.8) and community participants. No significant regional variation was observed. Multivariate analysis indicated age as the most important risk factor followed by ethnicity. Previous seasonal influenza vaccination was associated with higher HI titres. Approximately 45.2% of seropositive individuals reported no symptoms. CONCLUSIONS: Based on age and ethnicity standardisation to the New Zealand Population, about 29.5% of New Zealanders had antibody titers at a level consistent with immunity to 2009 H1N1. Around 18.3% of New Zealanders were infected with the virus during the first wave including about one child in every three. Older people were protected due to pre-existing immunity. Age was the most important factor associated with infection followed by ethnicity. Healthcare workers did not appear to have an increased risk of infection compared with the general population. Public Library of Science 2010-10-14 /pmc/articles/PMC2954793/ /pubmed/20976224 http://dx.doi.org/10.1371/journal.pone.0013211 Text en Bandaranayake et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Bandaranayake, Don
Huang, Q. Sue
Bissielo, Ange
Wood, Tim
Mackereth, Graham
Baker, Michael G.
Beasley, Richard
Reid, Stewart
Roberts, Sally
Hope, Virginia
Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic
title Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic
title_full Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic
title_fullStr Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic
title_full_unstemmed Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic
title_short Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic
title_sort risk factors and immunity in a nationally representative population following the 2009 influenza a(h1n1) pandemic
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954793/
https://www.ncbi.nlm.nih.gov/pubmed/20976224
http://dx.doi.org/10.1371/journal.pone.0013211
work_keys_str_mv AT bandaranayakedon riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic
AT huangqsue riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic
AT bissieloange riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic
AT woodtim riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic
AT mackerethgraham riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic
AT bakermichaelg riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic
AT beasleyrichard riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic
AT reidstewart riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic
AT robertssally riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic
AT hopevirginia riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic
AT riskfactorsandimmunityinanationallyrepresentativepopulationfollowingthe2009influenzaah1n1pandemic